Navigation Links
Vapotherm Announces New Exclusive Distribution Agreement with Hippo Medical for South Korea
Date:7/12/2011

STEVENSVILLE, Md., July 12, 2011 /PRNewswire-USNewswire/ -- Vapotherm, a privately held manufacturer of respiratory care devices for hospital and home use, announced today that it has signed a new exclusive distribution agreement with Hippo Medical of Seoul, Korea.  Hippo will cover all of Korea for the Vapotherm acute care product line.

"We are pleased to announce this new partnership with Hippo to bring high flow therapy to the Korean market," said Steve Orwig, Acute Care Manager with Vapotherm.  "We had several options for our distribution in Korea, but we ultimately selected Hippo based on the professionalism of their sales and marketing organization and the enthusiasm they share for the large market potential for high flow in the market."

Hwang Se Jung, Vice President at Hippo Medical, commented, "Hippo is pleased to represent the Vapotherm line in Korea, where we see strong potential for high flow therapy.  Vapotherm brings us clear clinical and technical leadership in high flow therapy, with innovative products like Precision Flow®, the only device in the category to integrate flow, gas blending and humidification control in one device for cost effective, non-invasive respiratory support via nasal cannula."

Hippo Medical was founded in 1976 and specializes in importing, marketing and distributing premium, innovative medical technologies to hospitals and clinicians.  Their product line includes airway management and other critical care technologies from manufacturers such as Covidien, Medis and Arcomed. For more information, visit www.hippomedical.co.kr.

Vapotherm, Inc. is a privately held manufacturer of respiratory care devices for hospitals and home care use based in Stevensville, Maryland. The Company is dedicated to the development of innovative, noninvasive technologies for respiratory therapy, especially for the treatment of chronic lung and acute breathing disorders. For more information, visit www.vtherm.com.

Contact:  Kevin Thibodeau, Executive Vice President of Sales and Marketing, 410-604-3977


'/>"/>
SOURCE Vapotherm, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vapotherm® Receives FDA 510(k) Clearance for Flowrest® Homecare Device
2. Vapotherm, Inc. Announces CE Mark Approval for Flowrest® Homecare Device
3. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
4. Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
5. Now Faster & Easier — Millennium Pharmacy Systems Announces New Release of MPSRx®
6. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
7. Surgical Care Affiliates Announces Agreement With Suburban Outpatient Surgery Center
8. Pinnaclife Announces Prenatal Nutrition Package and Mother Baby Skin Care Line
9. Metamark Genetics Announces Cancer Cell Study Highlighting Discovery of Key Molecules that Drive Progression of Malignant Melanoma in Humans
10. Vycor Medical, Inc. Announces Alvaro Pascual-Leone, MD, PhD as Head of the Strategic Advisory Board of its NovaVision, Inc. Subsidiary
11. Patient Advocate Foundation Announces Significant Operational, Technology Enhancements to Co-Pay Relief (CPR) Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Eli Lilly and Company (NYSE: LLY ) ... and lasmiditan, two investigational treatments for migraine, at the ... place Sept. 7-10 in Vancouver . ... from an open-label study evaluating the safety and effectiveness ... mg) for the prevention of migraine. Galcanezumab is a ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor , ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable design, ... Line of Model Homes . Independently, Ecocor and RPA have extensive experience with ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... inaugural SABRE Safe Is Smart Scholarship Sweepstakes.,  , Molli C., a graduate student ... MS in Educational Leadership and Administration at St. Thomas University in Miami, Florida, ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Cursed with a Curse: ... tithe, and the freedom experienced when breaking free from this misconception. “Cursed with ... M. Harrison. , Published by Christian Faith Publishing, Lysa M. Harrison’s new book ...
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... “Letters From Home”: a moving compilation of letters that ... God. “Letters From Home” is the creation of published author, John Allred, a passionate ... Jerry Savelle Ministries International, who has traveled and ministered on four continents. , “It ...
Breaking Medicine News(10 mins):